Your browser doesn't support javascript.
loading
Temporary Declines and Demand Resurgence: Gender-Affirming Surgery Volume and Complication Trends During and After the COVID-19 Pandemic.
Miller, Amitai S; Beagles, Clay B; Kaur, Manraj N; Marano, Andrew A; Hu, Sophia; Ghoshal, Soham; Dey, Tanujit; Coon, Devin; Succi, Marc D.
Afiliação
  • Miller AS; Harvard Medical School, Boston, MA, USA.
  • Beagles CB; Harvard University John F. Kennedy School of Government, Cambridge, MA, USA.
  • Kaur MN; Department of Surgery, Patient-Reported Outcomes, Value and Experience (PROVE) Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Marano AA; Harvard Medical School, Boston, MA, USA.
  • Hu S; Harvard Medical School, Boston, MA, USA.
  • Ghoshal S; Department of Surgery, Patient-Reported Outcomes, Value and Experience (PROVE) Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Dey T; Division of Plastic and Reconstructive Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Coon D; Department of Surgery, Patient-Reported Outcomes, Value and Experience (PROVE) Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Succi MD; Division of Plastic and Reconstructive Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Aesthetic Plast Surg ; 2024 Jul 11.
Article em En | MEDLINE | ID: mdl-38992249
ABSTRACT

BACKGROUND:

The COVID-19 pandemic prompted surgical volume reductions due to lockdown measures. This study evaluates COVID-19's impact on gender-affirming surgery (GAS) volume and complications from the pandemic onset through the recovery period.

METHODS:

The 2019-2021 National Surgical Quality Improvement Program databases were queried for transgender or gender-diverse patients using ICD-10 codes. Five time periods were analyzed Pre-pandemic, Immediate pre-pandemic and COVID-19 outbreak, Initial COVID-19 peak, Pre-COVID-19 vaccine, and Post-vaccine release. Complications included reoperation, urinary tract infections, and wound complications. Multivariate logistic regressions assessed factors associated with undergoing surgery during the initial COVID-19 peak and experiencing surgical complications.

RESULTS:

Out of 2,963,230 patients, 4637 underwent GAS between 2019 and 2021. Chest feminizing and masculinizing procedures comprised 60.1% of all GAS. During the initial COVID-19 peak, all GAS surgeries nearly halved, with breast augmentations dropping to 15.3% of pre-pandemic volumes. White patients constituted a significantly higher proportion of GAS patients during the initial COVID-19 peak than in 2019 (74.7% vs. 61.0%, p = 0.014). Post-vaccine, GAS levels surged, exceeding pre-pandemic volumes by 45.5% and initial peak levels by 188.5%. The overall complication rate was 4.9%, and was significantly associated with older age, increased operative time, feminizing and masculinizing genital surgeries, and hysterectomies. The initial COVID-19 peak showed no significant correlations with surgical complications.

CONCLUSIONS:

GAS volume temporarily decreased during the initial COVID-19 outbreak and has since rebounded and surpassed pre-pandemic levels, corresponding with past-decade trends. Complication risks remained consistent despite the pandemic, though the results highlight potentially significant race-based disparities in GAS access during COVID-19. IMPORTANT POINTS During the COVID-19 pandemic, public health measures led to severe volume reductions in gender-affirming surgical (GAS) procedures. Since the initial COVID-19 peak, GAS volumes have fully recovered and surpassed pre-pandemic volumes. Surgical complication rates for various GAS procedures were within expected ranges, emphasizing the overall safety of these surgeries. The study's results highlight racial disparities in undergoing GAS during the COVID-19 pandemic, with White patients disproportionately represented among those who had surgery during the COVID-19 lockdown. LEVEL OF EVIDENCE IV This journal requires that authors assign a level of evidence to each article. For a full description of these evidence-based medicine ratings, please refer to the Table of contents or the online Instructions to Authors www.springer.com/00266 .
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article